Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

KRT8 Antikörper

KRT8 Reaktivität: Human, Ratte, Zebrafisch (Danio rerio) WB, IF, FACS, IHC (p) Wirt: Maus Monoclonal K8-383 unconjugated
Produktnummer ABIN3024661
  • Target Alle KRT8 Antikörper anzeigen
    KRT8 (Keratin 8 (KRT8))
    Reaktivität
    • 254
    • 84
    • 72
    • 34
    • 31
    • 29
    • 28
    • 15
    • 14
    • 10
    • 8
    • 5
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    Human, Ratte, Zebrafisch (Danio rerio)
    Wirt
    • 141
    • 129
    • 3
    Maus
    Klonalität
    • 135
    • 135
    • 1
    Monoklonal
    Konjugat
    • 155
    • 21
    • 17
    • 9
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser KRT8 Antikörper ist unkonjugiert
    Applikation
    • 180
    • 120
    • 102
    • 81
    • 66
    • 47
    • 39
    • 39
    • 38
    • 36
    • 29
    • 22
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Aufreinigung
    Protein G affinity chromatography
    Immunogen
    Recombinant human Cytokeratin 8 protein was used as the immunogen for this antibody.
    Klon
    K8-383
    Isotyp
    IgG1
    Top Product
    Discover our top product KRT8 Primärantikörper
  • Applikationshinweise
    The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the antibody to be titered up or down for optimal performance.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 10  mM Citrate Buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. WB: 1-2 μg/mL,FACS: 0.5-1 μg/million cells,IF: 1-2 μg/mL,IHC (FFPE): 0.5-1.0 μg/mL for 30 min at RT (1),Prediluted format : incubate for 30 min at RT (2)

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    0.2 mg/mL
    Buffer
    0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store the Cytokeratin 8 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Target
    KRT8 (Keratin 8 (KRT8))
    Andere Bezeichnung
    Cytokeratin 8 (KRT8 Produkte)
    Hintergrund
    Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Antibody to Cytokeratin 8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against Cytokeratin 8, 18 and 19). Reportedly, Cytokeratin 8 antibody is useful for the differentiation of lobular (""ring-like, perinuclear"") from ductal (""peripheral-predominant"") carcinoma of the breast.
    Gen-ID
    3856
Sie sind hier:
Chat with us!